Cargando…
COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center
OBJECTIVE: To report outcomes on patients with multiple sclerosis (MS) and related disorders with coronavirus disease 2019 (COVID-19) illness. METHODS: From March 16 to April 30, 2020, patients with MS or related disorders at NYU Langone MS Comprehensive Care Center were identified with laboratory-c...
Autores principales: | Parrotta, Erica, Kister, Ilya, Charvet, Leigh, Sammarco, Carrie, Saha, Valerie, Charlson, Robert Erik, Howard, Jonathan, Gutman, Josef Maxwell, Gottesman, Malcolm, Abou-Fayssal, Nada, Wolintz, Robyn, Keilson, Marshall, Fernandez-Carbonell, Cristina, Krupp, Lauren B., Zhovtis Ryerson, Lana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357412/ https://www.ncbi.nlm.nih.gov/pubmed/32646885 http://dx.doi.org/10.1212/NXI.0000000000000835 |
Ejemplares similares
-
Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies
por: Smith, Tyler E, et al.
Publicado: (2022) -
Incomplete Susac syndrome exacerbated after natalizumab
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2015) -
Telehealth transcranial direct current stimulation for recovery from Post-Acute Sequelae of SARS-CoV-2 (PASC)
por: Eilam-Stock, Tehila, et al.
Publicado: (2021) -
Pharmacodynamics of natalizumab extended interval dosing in MS
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2020) -
The NYU Osteoporosis Model of Care Experience
por: Saxena, Amit, et al.
Publicado: (2015)